Abstract
The X-linked form of Charcot–Marie–Tooth disease (CMTX) is the second most common form of this genetically heterogeneous inherited peripheral neuropathy. CMT1X is caused by mutations in the GJB1 gene. Most of the mutations causative for CMT1X are missense mutations. In addition, a few disease causative nonsense mutations and frameshift deletions that lead to truncated forms of the protein have also been reported to be associated with CMT1X. Previously, there have been reports of patients with deletions of the coding sequence of GJB1; however, the size and breakpoints of these deletions were not assessed. Here, we report five patients with deletions that range in size from 12.2 to 48.3 kb and that completely eliminate the entire coding sequence of the GJB1 gene, resulting in a null allele for this locus. Analyses of the breakpoints of these deletions showed that they are nonrecurrent and that they can be generated by different mechanisms. In addition to PMP22, GJB1 is the second CMT gene for which both point mutations and genomic rearrangements can cause a neuropathy phenotype, stressing the importance of CMT as a genomic disorder.
This is a preview of subscription content, log in via an institution to check access.
References
England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA, Asbury AK, Szigeti K, Lupski JR, Latov N, Lewis RA, Low PA, Fisher MA, Herrmann DN, Howard JF Jr, Lauria G, Miller RG, Polydefkis M, Sumner AJ (2009) Practice parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology 72:185–192
Pareyson D, Marchesi C (2009) Diagnosis, natural history, and management of Charcot–Marie–Tooth disease. Lancet Neurol 8:654–667
Lupski JR, de Oca-Luna RM, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, Saucedo-Cardenas O, Barker DF, Killian JM, Garcia CA, Chakravarti A, Patel PI (1991) DNA duplication associated with Charcot–Marie–Tooth disease type 1A. Cell 66:219–232
Raeymaekers P, Timmerman V, Nelis E, De Jonghe P, Hoogenduk JE, Baas F, Barker DF, Martin JJ, De Visser M, Bolhuis PA, Van Broeckhoven C (1991) Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). Neuromuscul Disord 1:93–97
Chance PF, Abbas N, Lensch MW, Pentao L, Roa BB, Patel PI, Lupski JR (1994) Two autosomal dominant neuropathies result from reciprocal DNA duplication/deletion of a region on chromosome 17. Hum Mol Genet 3:223–228
Chance PF, Alderson MK, Leppig KA, Lensch MW, Matsunami N, Smith B, Swanson PD, Odelberg SJ, Disteche CM, Bird TD (1993) DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 72:143–151
Bergoffen J, Scherer SS, Wang S, Scott MO, Bone LJ, Paul DL, Chen K, Lensch MW, Chance PF, Fischbeck KH (1993) Connexin mutations in X-linked Charcot–Marie–Tooth disease. Science 262:2039–2042
Söhl G, Gillen C, Bosse F, Gleichmann M, Muller H, Willecke K (1996) A second alternative transcript of the gap junction gene connexin32 is expressed in murine Schwann cells and modulated in injured sciatic nerve. Eur J Cell Biol 69:267–275
Kleopa K, Scherer S (2006) Molecular genetics of X-linked Charcot–Marie–Tooth disease. Neuromolecular Med 8:107–122
Ressot C, Gomes D, Dautigny A, Pham-Dinh D, Bruzzone R (1998) Connexin32 mutations associated with X-linked Charcot–Marie–Tooth disease show two distinct behaviors: loss of function and altered gating properties. J Neurosci 18:4063–4075
Shy ME, Siskind C, Swan ER, Krajewski KM, Doherty T, Fuerst DR, Ainsworth PJ, Lewis RA, Scherer SS, Hahn AF (2007) CMT1X phenotypes represent loss of GJB1 gene function. Neurology 68:849–855
Ainsworth PJ, Bolton CF, Murphy BC, Stuart JA, Hahn AF (1998) Genotype/phenotype correlation in affected individuals of a family with a deletion of the entire coding sequence of the connexin 32 gene. Hum Genet 103:242–244
Lin C, Numakura C, Ikegami T, Shizuka M, Shoji M, Nicholson G, Hayasaka K (1999) Deletion and nonsense mutations of the connexin 32 gene associated with Charcot–Marie–Tooth disease. Tohoku J Exp Med 188:239–244
Nakagawa M, Takashima H, Umehara F, Arimura K, Miyashita F, Takenouchi N, Matsuyama W, Osame M (2001) Clinical phenotype in X-linked Charcot–Marie–Tooth disease with an entire deletion of the connexin 32 coding sequence. J Neurol Sci 185:31–37
Hahn AF, Ainsworth PJ, Naus CCG, Mao J, Bolton CF (2000) Clinical and pathological observations in men lacking the gap junction protein connexin 32. Muscle Nerve 23:S39–S48
Takashima H, Nakagawa M, Umehara F, Hirata K, Suehara M, Mayumi H, Yoshishige K, Matsuyama W, Saito M, Jonosono M, Arimura K, Osame M (2003) Gap junction protein beta 1 (GJB1) mutations and central nervous system symptoms in X-linked Charcot–Marie–Tooth disease. Acta Neurol Scand 107:31–37
Lee JA, Carvalho CMB, Lupski JR (2007) A DNA replication mechanism for generating nonrecurrent rearrangements associated with genomic disorders. Cell 131:1235–1247
Sen SK, Han K, Wang J, Lee J, Wang H, Callinan PA, Dyer M, Cordaux R, Liang P, Batzer MA (2006) Human genomic deletions mediated by recombination between Alu elements. 79:41-53.
Lieber MR (2008) The mechanism of human nonhomologous DNA end joining. J Biol Chem 283:1–5
Gu W, Zhang F, Lupski J (2008) Mechanisms for human genomic rearrangements. Patho Genetics 1:4
Zhang F, Carvalho CMB, Lupski JR (2009) Complex human chromosomal and genomic rearrangements. Trends Genet 25:298–307
Hastings PJ, Ira G, Lupski JR (2009) A Microhomology-mediated break-induced replication model for the origin of human copy number variation. PLoS Genet 5:e1000327
Zhang F, Khajavi M, Connolly AM, Towne CF, Batish SD, Lupski JR (2009) The DNA replication FoSTeS/MMBIR mechanism can generate genomic, genic and exonic complex rearrangements in humans. Nat Genet 41:849–853
Carvalho CMB, Zhang F, Liu P, Patel A, Sahoo T, Bacino CA, Shaw C, Peacock S, Pursley A, Tavyev YJ, Ramocki MB, Nawara M, Obersztyn E, Vianna-Morgante AM, Stankiewicz P, Zoghbi HY, Cheung SW, Lupski JR (2009) Complex rearrangements in patients with duplications of MECP2 can occur by fork stalling and template switching. Hum Mol Genet 18:2188–2203
Scherer SS, Xu Y-T, Nelles E, Fischbeck KH, Willecke K, Bone LJ (1998) Connexin32-null mice develop demyelinating peripheral neuropathy. Glia 24:8–20
Scherer SS, Xu Y-T, Messing A, Willecke K, Fischbeck KH, Jeng LJB (2005) Transgenic expression of human connexin32 in myelinating schwann cells prevents demyelination in connexin32-null mice. J Neurosci 25:1550–1559
Acknowledgements
The authors wish to thank Pengfei Liu, Claudia Carvalho, and Magdalena Bartnik for their help and insights. This work was supported in part by the National Institute of Neurological Disorders and Stroke (National Institutes of Health) grant R01NS058529 to J.R.L.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gonzaga-Jauregui, C., Zhang, F., Towne, C.F. et al. GJB1/Connexin 32 whole gene deletions in patients with X-linked Charcot–Marie–Tooth disease. Neurogenetics 11, 465–470 (2010). https://doi.org/10.1007/s10048-010-0247-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10048-010-0247-4